Anna P. Koo

1.2k total citations
38 papers, 935 citations indexed

About

Anna P. Koo is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Anna P. Koo has authored 38 papers receiving a total of 935 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 12 papers in Immunology and 10 papers in Oncology. Recurrent topics in Anna P. Koo's work include Complement system in diseases (9 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Platelet Disorders and Treatments (6 papers). Anna P. Koo is often cited by papers focused on Complement system in diseases (9 papers), Hematopoietic Stem Cell Transplantation (6 papers) and Platelet Disorders and Treatments (6 papers). Anna P. Koo collaborates with scholars based in United States, Russia and South Korea. Anna P. Koo's co-authors include Lisa Rybicki, Paul S. Malchesky, Alejandro C. Arroliga, Adrian O’Hagan, Paul C. Stillwell, Brian J. Bolwell, Frances Lynn, Susan Goelz, Richard M. Ransohoff and James R. Woodworth and has published in prestigious journals such as Blood, Neurology and Brain Research.

In The Last Decade

Anna P. Koo

36 papers receiving 906 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna P. Koo United States 15 298 272 238 180 179 38 935
Mariaelisa Rampudda Italy 11 137 0.5× 402 1.5× 48 0.2× 90 0.5× 194 1.1× 15 1.2k
Ken Yamaji Japan 19 120 0.4× 510 1.9× 82 0.3× 97 0.5× 82 0.5× 135 1.3k
Xiaohui Zhang China 18 382 1.3× 165 0.6× 129 0.5× 77 0.4× 97 0.5× 94 900
Weiyan Zheng China 14 351 1.2× 167 0.6× 199 0.8× 53 0.3× 36 0.2× 71 800
Yngvar Fløisand Norway 20 520 1.7× 513 1.9× 189 0.8× 124 0.7× 36 0.2× 77 1.2k
Ryuji Nakagawa Japan 16 399 1.3× 136 0.5× 151 0.6× 80 0.4× 23 0.1× 55 838
M. Abe Japan 13 49 0.2× 105 0.4× 69 0.3× 94 0.5× 58 0.3× 59 542
Matthew Buckland United Kingdom 19 136 0.5× 662 2.4× 78 0.3× 68 0.4× 94 0.5× 54 1.1k
Jocelyn R. Farmer United States 14 99 0.3× 457 1.7× 144 0.6× 76 0.4× 98 0.5× 50 939
Nadine Unterwalder Germany 19 36 0.1× 325 1.2× 89 0.4× 157 0.9× 60 0.3× 32 906

Countries citing papers authored by Anna P. Koo

Since Specialization
Citations

This map shows the geographic impact of Anna P. Koo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna P. Koo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna P. Koo more than expected).

Fields of papers citing papers by Anna P. Koo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna P. Koo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna P. Koo. The network helps show where Anna P. Koo may publish in the future.

Co-authorship network of co-authors of Anna P. Koo

This figure shows the co-authorship network connecting the top 25 collaborators of Anna P. Koo. A scholar is included among the top collaborators of Anna P. Koo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna P. Koo. Anna P. Koo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koo, Anna P., Ji-Yong Park, Yun‐Sang Lee, et al.. (2025). Feasibility of Anti-CEA Dye Conjugate for Cancer-Specific Imaging in Gastric Cancer Cell Lines and Mouse Xenograft Models. Cancers. 17(17). 2937–2937.
2.
Khouri, Jack, Lisa Rybicki, Navneet S. Majhail, et al.. (2019). Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantation. Journal of Clinical Apheresis. 34(6). 638–645. 5 indexed citations
3.
Bolwell, Brian J., Lisa Rybicki, Hien Duong, et al.. (2011). Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation. Bone Marrow Transplantation. 46(12). 1519–1525. 8 indexed citations
4.
Flechner, Stuart M., Richard Fatica, Medhat Askar, et al.. (2010). The Role of Proteasome Inhibition With Bortezomib in the Treatment of Antibody-Mediated Rejection After Kidney-Only or Kidney-Combined Organ Transplantation. Transplantation. 90(12). 1486–1492. 87 indexed citations
5.
Copelan, Edward A., Brad Pohlman, Lisa Rybicki, et al.. (2008). A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma. Bone Marrow Transplantation. 43(2). 101–105. 11 indexed citations
6.
Malchesky, Paul S., et al.. (2007). Apheresis Technologies and Clinical Applications: The 2005 International Apheresis Registry. Therapeutic Apheresis and Dialysis. 11(5). 341–362. 38 indexed citations
7.
Malchesky, Paul S., et al.. (2004). Apheresis Technologies and Clinical Applications: The 2002 International Apheresis Registry. Therapeutic Apheresis and Dialysis. 8(2). 124–143. 22 indexed citations
8.
Ramasubbu, Kumudha, Tarun Mullick, Anna P. Koo, et al.. (2003). Thrombotic microangiopathy and cytomegalovirus in liver transplant recipients: a case‐based review. Transplant Infectious Disease. 5(2). 98–103. 40 indexed citations
9.
Koo, Anna P.. (2000). Therapeutic apheresis in autoimmune and rheumatic diseases. Journal of Clinical Apheresis. 15(1-2). 18–27. 28 indexed citations
10.
O’Hagan, Adrian, Paul C. Stillwell, Alejandro C. Arroliga, & Anna P. Koo. (1999). Photopheresis in the Treatment of Refractory Bronchiolitis Obliterans Complicating Lung Transplantation. CHEST Journal. 115(5). 1459–1462. 68 indexed citations
11.
Bolwell, Brian J., Marlene Goormastic, S Andresen, et al.. (1998). Variables associated with the platelet count 6 weeks after autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplantation. 22(6). 547–551. 7 indexed citations
12.
Grob, David, David Simpson, Hiroshi Mitsumoto, et al.. (1995). Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology. 45(2). 338–344. 85 indexed citations
13.
Siami, Ghodrat A., Walter L. Wilkins, William J. Stone, Anna P. Koo, & Maciej Zborowski. (1994). Clinical Trials of a Cryoglobulin Filter. ASAIO Journal. 40(3). M658–M662. 12 indexed citations
14.
Sawada, Koji, Paul S. Malchesky, Jun Tanaka, et al.. (1994). Defective leukocyte function‐related cryoprecipitable protein in Cryoglobulinemia. Journal of Clinical Apheresis. 9(4). 210–215. 1 indexed citations
15.
Malchesky, Paul S., et al.. (1993). Are Selective Macromolecule Removal Plasmapheresis Systems Useful for Autoimmune Diseases or Hyperlipidemia?. ASAIO Journal. 39(4). 868–872. 4 indexed citations
16.
Brouhard, Ben H., Koji Sawada, Paul S. Malchesky, Anna P. Koo, & Hiroshi Mitsumoto. (1993). Myasthenia gravis therapy: immunoadsorbent may eliminate need for plasma products. Cleveland Clinic Journal of Medicine. 60(1). 60–64. 5 indexed citations
17.
Malchesky, Paul S., et al.. (1993). Are Selective Macromolecule Removal Plasmapheresis Systems Useful for Autoimmune Diseases or Hyperlipidemia?. ASAIO Journal. 39(4). 868–872. 5 indexed citations
18.
Sawada, Koji, Paul S. Malchesky, Maciej Zborowski, & Anna P. Koo. (1992). Selective removal of anti‐acetylcholine receptor antibody in the low temperature operation of membrane plasma fractionation. Journal of Clinical Apheresis. 7(2). 81–86. 2 indexed citations
19.
Sawada, Koji, et al.. (1992). Backwashing procedure for on‐line reuse of a plasma fractionator in cryofiltration. Journal of Clinical Apheresis. 7(2). 87–92. 2 indexed citations
20.
Sawada, Koji, et al.. (1991). Rapid improvement in a patient with leukocytoclastic vasculitis with secondary mixed cryoglobulinemia treated with cryofiltration.. PubMed. 18(1). 91–4. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mariaelisa Rampudda Breakdown of academic impact, for papers by Ken Yamaji Breakdown of academic impact, for papers by Xiaohui Zhang Breakdown of academic impact, for papers by Weiyan Zheng Breakdown of academic impact, for papers by Yngvar Fløisand Breakdown of academic impact, for papers by Ryuji Nakagawa Breakdown of academic impact, for papers by M. Abe Breakdown of academic impact, for papers by Matthew Buckland Breakdown of academic impact, for papers by Jocelyn R. Farmer Breakdown of academic impact, for papers by Nadine Unterwalder
Rankless by CCL
2026